发明名称 |
IMPROVED METHOD FOR TREATMENT OF PATIENTS WITH CYSTIC FIBROSIS |
摘要 |
A method for treatment of patients with cystic fibrosis by providing an inhalable aerosol comprising a mucolytic compound (dornase alpha) administered into a patient's lungs according to a specific treatment protocol setting comprising a mucolytic drug containing aerosol having particles with a predetermined mass medial aerodynamic diameter (MMAD) delivered predominantly to a peripheral lungs using a nebulizing system able to administer said aerosol with overpressure and under controlled breathing conditions. |
申请公布号 |
EP2482903(A1) |
申请公布日期 |
2012.08.08 |
申请号 |
EP20100763129 |
申请日期 |
2010.09.29 |
申请人 |
ACTIVAERO GMBH;ERASMUS MC-SOPHIA CHILDREN'S HOSPITAL |
发明人 |
KRONEBERG, PHILIPP;MUELLINGER, BERNHARD;TIDDENS, HARM A. W. N.;VAN DEN BEUKEL-BAKKER, MARIJE |
分类号 |
A61M15/00;A61K38/08;G07F15/00 |
主分类号 |
A61M15/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|